Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Subsequent Events

"During the period September 1, 2011 through October 7, 2011, we purchased 140,500 shares of our common stock at an aggregate cost of $6,668 pursuant to our stock buyback program."

Average cost: $0.0475. % of outstanding shares repurchased by company: 0.034%.
At least they bought on the lows, but why even bother?

Other CFOs must be laughing until they cry at such a pathetic "buy back" execution.

Maybe Gloria should have bought a new calculator or upgraded her Excel before she approved it (maybe she's still on Visicalc).
With $9M in the bank, this could have been 500 times bigger at such a bargain/basement price.
140,500x500 = 7,0250,000 @ $0.05 = $3.5M. Still only 1.63% but at least a bit more realistic.

If we're no longer funding PDS (see 10-Q) then all we have to spend the other $6M on would be lawyers, accountants and BOD members, plus shutting the doors on PDSG. They could also cut the rent and let Cliff work from home AND anser the phones himself.


Share
New Message
Please login to post a reply